Expression of estrogen and androgen receptors in differentiated thyroid cancer: an additional criterion to assess the patient's risk

Androgen receptor expression in human thyroid cancer tissues: A potential mechanism underlying the gender bias in the incidence of thyroid cancers

(2012) J.A. Stanley et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

The prognostic impact of tumor cell expression of estrogen receptor-α, progesterone receptor, and androgen receptor in patients irradiated for nonsmall cell lung cancer

(2011) Dirk Rades et al.   CANCER

Long-Term Follow-Up of Patients with Papillary and Follicular Thyroid Cancer: A Prospective Study on 715 Patients

(2011) M. Brassard et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation

(2011) Ozgur Mete et al.   MODERN PATHOLOGY

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Steroid hormone receptors in cancer development: A target for cancer therapeutics

(2010) Nihal Ahmad et al.   CANCER LETTERS

Metastatic Phenotype Is Regulated by Estrogen in Thyroid Cells

(2010) Shilpi Rajoria et al.   THYROID

Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy

(2009) Guia Vannucchi et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Reproductive and Menstrual Factors and Thyroid Cancer among Japanese Women: The Japan Collaborative Cohort Study

(2009) Truong-Minh Pham et al.   JOURNAL OF WOMENS HEALTH

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

(2009) David S. Cooper et al.   THYROID

Risk Factors for Nodal Metastasis and Recurrence Among Patients with Papillary Thyroid Microcarcinoma: Differences in Clinical Relevance Between Nonincidental and Incidental Tumors

(2009) Adolfo Pisanu et al.   WORLD JOURNAL OF SURGERY

Regulation of Cell Growth by Estrogen Signaling and Potential Targets in Thyroid Cancer

(2008) George Chen et al.   CURRENT CANCER DRUG TARGETS

Oestrogen-receptor-positive breast cancer: towards bridging histopathological and molecular classifications

(2008) S Badve et al.   JOURNAL OF CLINICAL PATHOLOGY